• Recursion Pharmaceuticals (NASDAQ:RXRX) Receives "Buy" Rating from Needham & Company LLC

    المصدر: Buzz FX / 11 ديسمبر 2024 09:57:10   America/New_York


    Recursion Pharmaceuticals (NASDAQ:RXRX) Receives "Buy" Rating from Needham & Company LLC Written by MarketBeat December 11, 2024 Share Link copied to clipboard. Recursion Pharmaceuticals ( NASDAQ:RXRX - Get Free Report ) 's stock had its "b
    Read more...
شارك على،